aspirin has been researched along with tranexamic acid in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (23.53) | 18.7374 |
| 1990's | 4 (7.84) | 18.2507 |
| 2000's | 7 (13.73) | 29.6817 |
| 2010's | 25 (49.02) | 24.3611 |
| 2020's | 3 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ito, M; Sudo, Y; Suzuki, Y | 1 |
| Coeugniet, E | 1 |
| Tomikawa, M | 1 |
| Lindquist, O; Saldeen, T; Sandler, H | 1 |
| Schneider, J | 1 |
| Collen, D; De Mol, M; Declerck, PJ; Vaughan, DE | 1 |
| Hamada, K; Okada, Y; Sekiguchi, H; Taga, F | 1 |
| Aihara, H; Arai, I; Hirose, H; Isobe, Y; Murakami, S; Muramatsu, M; Usuki, C | 1 |
| Hoshina, K; Naruchi, T; Takeshita, T; Yamazaki, N | 1 |
| Cobo, R; Lasierra, J; López-Campos, JL; Moreno, J; Navas, P; Piñero, J | 1 |
| Gillingham, FJ; Hayes, J; Mendelow, AD; Steers, AJ; Stockdill, G | 1 |
| Bramsen, T; Ehlers, N; Olsen, T | 1 |
| Azuumi, Y; Hotta, K; Ishihara, K; Ohara, S; Okabe, H | 1 |
| Ishizuka, Y; Kamisaki, T; Kawashima, M; Matsuda, M; Sato, M; Shimazaki, I; Terashima, K; Yaginuma, H | 1 |
| Carter, C; Landymore, RW; Lummis, H; Murphy, JT | 1 |
| Kambayashi, J; Lockyer, S | 1 |
| Bjella, L; Dale, O; Karevold, A; Pleym, H; Stenseth, R; Wahba, A | 1 |
| Tjønnfjord, GE | 1 |
| Abe, T; Haraguchi, M; Hayashi, M; Ito, K; Nakajima, H; Sakagami, T; Tsutsui, N | 1 |
| Aframian, DJ; Lalla, RV; Peterson, DE | 1 |
| Buxton, B; Cooper, DJ; Esmore, DS; Forbes, A; Knight, J; Krum, H; McNeil, J; Myles, PS; Silbert, B; Smith, J; Tonkin, A | 1 |
| Dunning, J; Fabbri, A; Kolh, P; Lockowandt, U; Nashef, SA; Pavie, A; Versteegh, M | 1 |
| Byhahn, C; Görlinger, K; Hanke, AA; Meininger, D; Moritz, A; Weber, CF; Zacharowski, K | 1 |
| Ahmad, M; Fatima, N; Imran, H; Rahman, A; Rehman, Z; Sohail, T; Yaqeen, Z | 1 |
| Bains, R; Bains, VK; Loomba, A; Loomba, K | 1 |
| DeSimone, LJ; Gillette, BP; Pagnano, MW; Sierra, RJ; Trousdale, RT | 1 |
| Ji, H; Li, L; Lv, H; Shi, J; Wang, G; Wang, Y; Yuan, S | 1 |
| Sellke, FW | 1 |
| Li, LH; Shi, J; Wang, GY; Wang, YF; Xue, QH; Yuan, S | 1 |
| Aoki, M; Baba, H; Goto, Y; Ogawa, S; Okawa, Y | 1 |
| Myles, PS | 1 |
| Chen, AF; Heller, S; Parvizi, J; Secrist, E; Shahi, A | 1 |
| Barksdale, LC; Calvo, C; McNamara, CA; Patel, PD; Suarez, JC; Szubski, CR | 1 |
| Musgrave, KM; Powell, J | 1 |
| Bussières, JS; Byrne, K; Chan, MT; Cooper, DJ; Forbes, A; Jayarajah, M; Landoni, G; Marasco, S; McGuinness, S; McNeil, J; Myles, PS; Painter, T; Silbert, B; Smith, JA; Wallace, S | 1 |
| Hsue, SS; Lin, LH; Lu, SY | 1 |
| Bussières, JS; Chan, MTV; Cooper, DJ; Forbes, A; Jayarajah, M; Kasza, J; Marasco, S; McGuinness, S; McNeil, J; Myles, PS; Painter, T; Silbert, B; Smith, JA; Wallace, S | 1 |
| Lamy, A | 1 |
| Bozinovski, J | 1 |
| Hawkins, RB; Mehaffey, JH | 1 |
| Bussières, JS; Byrne, K; Chan, MTV; Cooper, DJ; Forbes, A; Jayarajah, M; Kasza, J; Landoni, G; Marasco, S; McGuinness, S; McNeil, J; Myles, PS; Painter, T; Silbert, B; Smith, JA; Wallace, S | 1 |
| Gharaibeh, A; Goldberg, MF; Lindsley, K; Savage, HI; Scherer, RW | 1 |
| Ke, X; Qiu, J; Sun, X; Yang, G; Zhang, L; Zhang, W | 1 |
| Mastel, MS; van der Merwe, JM | 1 |
| Ashkenazi, I; Chechik, O; Gold, A; Gurel, R; Schermann, H; Schwarzkopf, R; Snir, N; Warschawski, Y | 1 |
| Gharaibeh, A; Goldberg, MF; Lindsley, KB; Ng, SM; Scherer, RW; Woreta, FA | 1 |
7 review(s) available for aspirin and tranexamic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of dental patients taking common hemostasis-altering medications.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Dental Care for Chronically Ill; Humans; International Normalized Ratio; Mouthwashes; Prothrombin Time; Tranexamic Acid; Warfarin | 2007 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evidence-Based Medicine; Heart Valve Prosthesis Implantation; Hemostasis, Surgical; Hemostatics; Humans; Monitoring, Intraoperative; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Ticlopidine; Tranexamic Acid; Warfarin | 2008 |
A systematic review of anti-thrombotic therapy in epistaxis.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Clopidogrel; Dabigatran; Disease Management; Epistaxis; Humans; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Ticlopidine; Tranexamic Acid; Warfarin | 2016 |
Medical interventions for traumatic hyphema.
Topics: Adrenal Cortex Hormones; Aminocaproic Acid; Antifibrinolytic Agents; Aspirin; Bandages; Bed Rest; Child; Estrogens, Conjugated (USP); Eye Injuries; Humans; Hyphema; Mydriatics; Patient Positioning; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tranexamic Acid; Visual Acuity; Wounds, Nonpenetrating | 2019 |
Controversial Topics in Total Knee Arthroplasty: A Five-Year Update (Part 2).
Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Tourniquets; Tranexamic Acid; Venous Thromboembolism; Warfarin; Wound Closure Techniques | 2020 |
Medical interventions for traumatic hyphema.
Topics: Adrenal Cortex Hormones; Aminocaproic Acid; Antifibrinolytic Agents; Aspirin; Glaucoma; Humans; Hyphema; Mydriatics; Tranexamic Acid | 2023 |
11 trial(s) available for aspirin and tranexamic acid
| Article | Year |
|---|---|
Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage.
Topics: Angiography; Aphasia; Aspirin; Double-Blind Method; Female; Hemiplegia; Humans; Intracranial Aneurysm; Male; Subarachnoid Hemorrhage; Tranexamic Acid | 1982 |
The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Humans; Postoperative Hemorrhage; Tranexamic Acid; Treatment Outcome | 1997 |
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion; Coronary Artery Bypass; Creatinine; Double-Blind Method; Female; Hematocrit; Hemoglobins; Heparin; Heparin Antagonists; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Postoperative Hemorrhage; Prospective Studies; Protamines; Sample Size; Tranexamic Acid | 2003 |
Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design.
Topics: Antifibrinolytic Agents; Aspirin; Coronary Artery Bypass; Epidemiologic Research Design; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Tranexamic Acid | 2008 |
Tranexamic Acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up.
Topics: Antifibrinolytic Agents; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors; Tranexamic Acid; Treatment Outcome | 2013 |
[Effectiveness and safety of tranexamic acid in patients receiving on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation].
Topics: Aged; Aged, 80 and over; Aspirin; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Ticlopidine; Tranexamic Acid | 2013 |
Closed Suction Drainage Has No Benefits in Anterior Hip Arthroplasty: A Prospective, Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Aspirin; Blood Loss, Surgical; Blood Transfusion; Drainage; Female; Fibrinolytic Agents; Hematoma; Hemoglobins; Hemostasis, Surgical; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Suction; Tranexamic Acid; Venous Thromboembolism | 2016 |
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Heart Valves; Hemorrhage; Humans; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Reoperation; Seizures; Thrombosis; Tranexamic Acid | 2017 |
Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial.
Topics: Aged; Antifibrinolytic Agents; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Disability Evaluation; Double-Blind Method; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Progression-Free Survival; Risk Factors; Time Factors; Tranexamic Acid | 2019 |
Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial.
Topics: Activities of Daily Living; Aged; Antifibrinolytic Agents; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Disability Evaluation; Double-Blind Method; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Progression-Free Survival; Risk Factors; Time Factors; Tranexamic Acid | 2019 |
Effect of topical tranexamic acid in total hip arthroplasty patients who receive continuous aspirin for prevention of cardiovascular or cerebrovascular events: A prospective randomized study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Tranexamic Acid | 2019 |
33 other study(ies) available for aspirin and tranexamic acid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Studies on the mechanism of action of cetraxate [4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride], a new anti-ulcer agent.
Topics: Acetates; Animals; Anti-Ulcer Agents; Aspirin; Connective Tissue; Cyclohexanecarboxylic Acids; Female; Fibrinolysis; Glycosaminoglycans; Hexosamines; Hydroxyproline; Rats; Sialic Acids; Stomach Ulcer; Tranexamic Acid; Uronic Acids | 1979 |
Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.
Topics: Adult; Aprotinin; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Concanavalin A; Dipyridamole; Female; Humans; Lymphocyte Activation; Lymphokines; Male; Phenylmethylsulfonyl Fluoride; Platelet Aggregation; Thrombosis; Tranexamic Acid | 1979 |
Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
Topics: Animals; Aspirin; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinolysis; Heparin; Lactates; Male; Platelet Aggregation; Pulmonary Embolism; Rats; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1975 |
Pulmonary damage following pulmonary microembolism in the dog. Effect of various types of treatment.
Topics: Animals; Aspirin; Calcium; Cyclohexanecarboxylic Acids; Dogs; Female; Indomethacin; Lung; Male; Methylprednisolone; Methysergide; Microcirculation; Phenoxybenzamine; Polyphloretin Phosphate; Pulmonary Edema; Pulmonary Embolism; Pyrilamine; Reserpine; Thrombin; Tranexamic Acid; Vascular Resistance | 1976 |
Interactions of saruplase with acetylsalicylic acid, heparin, glyceryl trinitrate, tranexamic acid and aprotinin in a rabbit pulmonary thrombosis model.
Topics: Animals; Aprotinin; Aspirin; Heparin; Iodine Radioisotopes; Male; Nitroglycerin; Plasminogen Activators; Plasminogen Inactivators; Pulmonary Embolism; Rabbits; Recombinant Proteins; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1990 |
Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.
Topics: Animals; Aspirin; Drug Combinations; Glycoproteins; Hemorrhage; Hemostasis; Plasminogen Inactivators; Rabbits; Recombinant Proteins; Tissue Plasminogen Activator; Tranexamic Acid | 1989 |
[Effects of troxipide on acute gastric lesions in rats].
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Aspirin; Ethanol; Gastric Mucosa; Hydrochloric Acid; Immersion; Male; Piperidines; Rats; Stomach Diseases; Stress, Physiological; Tranexamic Acid | 1987 |
Effect of sofalcone on acute gastric mucosal lesions induced by aspirin and ethanol in reference to the biosynthesis of gastric mucosal glycoprotein.
Topics: Animals; Aspirin; Chalcone; Chalcones; Ethanol; Gastric Mucosa; Gastritis; Glucosamine; Glycoproteins; Male; Propiophenones; Rats; Sulfates; Tranexamic Acid | 1986 |
Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
Topics: Acetates; Acetic Acid; Aminopyrine; Animals; Anti-Ulcer Agents; Aspirin; Bethanechol Compounds; Cimetidine; Dogs; Gastric Juice; Gastric Mucosa; Gastrointestinal Hemorrhage; Indomethacin; Male; Phenylpropionates; Pylorus; Rats; Rats, Inbred Strains; Regional Blood Flow; Serotonin; Stomach Ulcer; Stress, Physiological; Tranexamic Acid | 1985 |
[Changes in mucopolysaccharides and ultrastructural alterations in experimental atheromatosis].
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Diet, Atherogenic; Dipyridamole; Endothelium; Fibrinolytic Agents; Glycosaminoglycans; Rabbits; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1982 |
Influence of tranexamic acid and acetylsalicylic acid on the thickness of the normal cornea.
Topics: Adult; Aspirin; Cornea; Cyclohexanecarboxylic Acids; Endothelium; Female; Humans; Male; Tranexamic Acid | 1980 |
Efficacy of anti-ulcer drugs on the recovery of gastric mucosal glycoproteins with aspirin-induced gastric damage in rat.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cimetidine; Gastric Mucosa; Glycoproteins; Male; Rats; Rats, Inbred Strains; Tranexamic Acid | 1981 |
Anti-ulcer effect of 1,6-dihydro-2-[2-(2-methylpropoxy) anilino]-6-oxo-5-pyrimidinecarboxylic acid on experimental gastric ulcers in rats.
Topics: Acetates; Animals; Anti-Ulcer Agents; Aspirin; Cimetidine; Ethanol; Hydrochloric Acid; Male; p-Methoxy-N-methylphenethylamine; Pylorus; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium Hydroxide; Stomach Ulcer; Stress, Psychological; Tranexamic Acid | 1994 |
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Carotid Artery Diseases; Carotid Artery, Common; Chlorides; Ferric Compounds; Fibrinolytic Agents; Heparin; Hirudins; Immune Sera; Ligation; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thrombosis; Tranexamic Acid | 1999 |
[Anticoagulation therapy and oral surgery].
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Humans; Oral Hemorrhage; Risk Factors; Tooth Extraction; Tranexamic Acid; Warfarin | 2005 |
[A case of acute exacerbation of chronic pulmonary thromboembolism with essential thrombocythemia during treatment for hemoptysis].
Topics: Aged, 80 and over; Antifibrinolytic Agents; Aspirin; Chronic Disease; Female; Hemoptysis; Humans; Oxygen Inhalation Therapy; Pulmonary Embolism; Respiratory Insufficiency; Thrombocytosis; Tranexamic Acid | 2006 |
Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy.
Topics: Aged; Antifibrinolytic Agents; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Ticlopidine; Tranexamic Acid | 2011 |
Pharmacological profile of Salvadora persica.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Behavior, Animal; Bleeding Time; Blood Coagulation; Diazepam; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ethanol; Hand Strength; Indomethacin; Mice; Pain Measurement; Plant Extracts; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Salvadoraceae; Tranexamic Acid; Vitamin K | 2011 |
Management of a dentigerous cyst in a medically compromised geriatric patient: a case report.
Topics: Aged; Anesthetics, Local; Antifibrinolytic Agents; Aspirin; Bicuspid; Dental Care for Chronically Ill; Dentigerous Cyst; Epinephrine; Follow-Up Studies; Hemostatics; Humans; Lidocaine; Male; Mandibular Diseases; Nerve Block; Patient Care Planning; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Thromboembolism; Tooth, Impacted; Tranexamic Acid; Vasoconstrictor Agents | 2012 |
Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dalteparin; Female; Humans; Male; Retrospective Studies; Risk; Thromboembolism; Tranexamic Acid; Warfarin | 2013 |
Invited commentary.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Humans; Male; Ticlopidine; Tranexamic Acid | 2013 |
[Can local administration of tranexamic acid reduce aspirin-induced bleeding in off-pump coronary artery bypass grafting( CABG) ?].
Topics: Antifibrinolytic Agents; Aspirin; Coronary Artery Bypass, Off-Pump; Female; Hemorrhage; Humans; Male; Tranexamic Acid | 2013 |
Antifibrinolytics, aspirin and cardiac surgery: evidence, guidelines and implications for current research.
Topics: Antifibrinolytic Agents; Aspirin; Coronary Artery Bypass; Humans; Practice Guidelines as Topic; Tranexamic Acid | 2014 |
Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty; Aspirin; Blood Loss, Surgical; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Tranexamic Acid; Transfusion Reaction; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2016 |
Management of dental extractions in patients on warfarin and antiplatelet therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Clopidogrel; Female; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Taiwan; Tooth Extraction; Tranexamic Acid; Warfarin; Young Adult | 2018 |
Hacked by the Russians.
Topics: Aspirin; Coronary Artery Bypass; Russia; Tranexamic Acid | 2019 |
A perspective on the one-year results of the Aspirin and Tranexemic Acid for Coronary Artery Surgery trial.
Topics: Aspirin; Cardiac Surgical Procedures; Coronary Artery Bypass; Platelet Aggregation Inhibitors; Tranexamic Acid | 2019 |
A delicate balance: Bleeding versus thrombosis?
Topics: Aspirin; Coronary Artery Bypass; Hemorrhage; Humans; Thrombosis; Tranexamic Acid | 2019 |
Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Aspirin; Blood Loss, Surgical; Blood Transfusion; Cardiovascular Diseases; Deprescriptions; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Thromboembolism; Tranexamic Acid | 2020 |